Corning Life Sciences’ Elizabeth Abraham, Ph. D, UC San Diego Moores Cancer Center's Herve Tiriac, Ph.D., and Cold Spring Harbor Laboratory's Dennis Plenker, Ph.D., discuss the potential of 3-D organoids to revolutionize drug development and replace animal disease models.